Head-to-head
NovoCare Pharmacy (Wegovy) vs Enhance MD
Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. Enhance MD is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NovoCare Pharmacy (Wegovy) is $349 a month all-in for semaglutide; Enhance MD is $212. Over twelve months that is $4,188 against $2,544. Value Scores are 45.9 and 58.1 out of 100.
Semaglutide
Plan pages: NovoCare Pharmacy (Wegovy) plans · Enhance MD plans
At 2.4 mg/week, NovoCare Pharmacy (Wegovy) is $349 a month all-in and Enhance MD is $212 — $137 apart, or $1,644 across a year. Over twelve months the totals are $4,188 (billed monthly) and $2,544 (billed monthly).
NovoCare Pharmacy (Wegovy) charges a flat $349 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Enhance MD charges a flat $212 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | NovoCare Pharmacy (Wegovy) | Rank | Enhance MD | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $349 | 31/32 | $212 | 20/32 | Enhance MD by $137 |
| 0.5 mg | $349 | 21/21 | $212 | 14/21 | Enhance MD by $137 |
| 1 mg | $349 | 21/21 | $212 | 14/21 | Enhance MD by $137 |
| 1.7 mg | $349 | 21/21 | $212 | 14/21 | Enhance MD by $137 |
| 2.4 mg | $349 | 27/29 | $212 | 16/29 | Enhance MD by $137 |
Enhance MD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, NovoCare Pharmacy (Wegovy) sits 26 of 29 on all-in monthly cost and Enhance MD sits 13. There are 12 other programs priced between them. The field median is $249 and the floor is $129, so Enhance MD is below the median and the other is above it. NovoCare Pharmacy (Wegovy) is $220 above the cheapest semaglutide program on record. Enhance MD is $83 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — NovoCare Pharmacy (Wegovy) undercuts it by $0, Enhance MD by $137. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NovoCare Pharmacy (Wegovy) | Enhance MD | Cheaper |
|---|---|---|---|
| Month to month | $349 | $212 | Enhance MD by $137 |
| Settled dose | NovoCare Pharmacy (Wegovy) | Enhance MD | Difference |
|---|---|---|---|
| 0.25 mg | $4,188 | $2,544 | $1,644 apart |
| 0.5 mg | $4,188 | $2,544 | $1,644 apart |
| 1 mg | $4,188 | $2,544 | $1,644 apart |
| 1.7 mg | $4,188 | $2,544 | $1,644 apart |
| 2.4 mg | $4,188 | $2,544 | $1,644 apart |
NovoCare Pharmacy (Wegovy) publishes no rate for 3-month term, 6-month term, 12-month term; Enhance MD publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $4,188 on NovoCare Pharmacy (Wegovy) and $2,544 on Enhance MD. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 45.9 for NovoCare Pharmacy (Wegovy) and 58.1 for Enhance MD, against a semaglutide category floor of $129. Enhance MD leads by 12.2 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NovoCare Pharmacy (Wegovy) | 25.9 | 15.0 | 0 | 5 | 45.9 |
| Enhance MD | 42.6 | 10.5 | 0 | 5 | 58.1 |
Where the two programs differ
All-in monthly
Enhance MD is cheaper month to month — $212 against $349, a gap of $137 every month, or $1,644 across a year if both rates hold.
Cancellation terms
Cancellation differs: NovoCare Pharmacy (Wegovy) states No subscription lock, while Enhance MD states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NovoCare Pharmacy (Wegovy) asks for None; Enhance MD asks for Monthly, with a first-month discount on GLP-1 Core ($112 first month). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. NovoCare Pharmacy (Wegovy)'s figure is verified and Enhance MD's is reported. NovoCare Pharmacy (Wegovy) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $4,188 for NovoCare Pharmacy (Wegovy) and $2,544 for Enhance MD. Enhance MD is lower by $1,644 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both price by dose, so both advertised figures understate the cost of a titration year. Compare the ladders above rather than the headline rates.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NovoCare Pharmacy (Wegovy) Official site
Novo Nordisk's direct cash pharmacy sells FDA-approved Wegovy pens at $349/month across standard doses ($399 for the 7.2 mg HD pen), with a $199 introductory price on the first two starter-dose fills and oral Wegovy tablets from $149/month. It is the FDA-approved semaglutide price floor and the benchmark for every compounded semaglutide quote.
It names its compounding pharmacy — CoAssist Pharmacy d/b/a NovoCare Pharmacy, recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — novocare.com price guide and savings-offer pages, retrieved 2026-08-11
Watch: The $199 intro and the $149 oral tier both carry published expiration dates; the durable numbers are $349 pen / $399 HD.
Enhance MD Official site
Enhance MD bundles GLP-1 medication inside a broader metabolic program including NAD+ coaching, lab testing every six months, and ongoing provider care. The price reflects the full metabolic bundle, not the GLP-1 alone; this makes Enhance MD's figures the least comparable in the database.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not named), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, with a first-month discount on GLP-1 Core ($112 first month); cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Enhance MD GLP-1 Core verified 2026-07-14
Watch: Figures reflect the bundled metabolic program price, not GLP-1 medication alone. Comparing Enhance MD's $212–$322 to medication-only programs overstates the GLP-1 cost while understating the breadth of service included. The $169 microdosing figure is the most medication-proximate but involves a different dosing protocol. Reported — RangeYourself 2026-07-14.
Which molecules each one carries
NovoCare Pharmacy (Wegovy) carries semaglutide at $349 a month; does not offer tirzepatide.
Enhance MD carries tirzepatide at $280 a month and semaglutide at $212 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
NovoCare Pharmacy (Wegovy) does not publish
- no published twelve-month semaglutide rate
Enhance MD does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Ask NovoCare Pharmacy (Wegovy) and Enhance MD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Enhance MD carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Enhance MD Official site wins this matchup. And if you would rather trust a better-evidenced number, novocare pharmacy (wegovy)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NovoCare Pharmacy (Wegovy)'s semaglutide price is verified as of 2026-08-11; Enhance MD's is reported as of 2026-07-14.
Questions
Is NovoCare Pharmacy (Wegovy) or Enhance MD cheaper for semaglutide?
Enhance MD is cheaper on all-in monthly cost at 2.4 mg/week: $212 against $349, a difference of $137 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NovoCare Pharmacy (Wegovy) versus Enhance MD?
NovoCare Pharmacy (Wegovy) works out to $4,188 across twelve months and Enhance MD to $2,544, on the plan terms each publishes.
Does NovoCare Pharmacy (Wegovy) or Enhance MD raise the price as the dose goes up?
NovoCare Pharmacy (Wegovy): yes, it prices by dose. Enhance MD: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NovoCare Pharmacy (Wegovy) and Enhance MD differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NovoCare Pharmacy (Wegovy) and Enhance MD names its pharmacy?
NovoCare Pharmacy (Wegovy) does — CoAssist Pharmacy d/b/a NovoCare Pharmacy. Enhance MD does not, recording only Partner 503A pharmacy (not named), so who makes its medication cannot be independently verified.
How well evidenced are the NovoCare Pharmacy (Wegovy) and Enhance MD prices?
NovoCare Pharmacy (Wegovy)'s semaglutide figure is verified — captured at checkout by our desk on the stated date — captured 2026-08-11. Enhance MD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: NovoCare Pharmacy (Wegovy) official site · Enhance MD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.